Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by Theratechnologies
Sponsor:
Information provided by (Responsible Party):
Theratechnologies
ClinicalTrials.gov Identifier:
NCT01591902
First received: May 2, 2012
Last updated: August 12, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2024
  Estimated Primary Completion Date: December 2023 (Final data collection date for primary outcome measure)